Evidence map›Paper›PMID 39238178›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2024

Knowledge and Awareness Toward Menopausal Hormone Therapy in a Fourth-Tier City of China.

Rui Li, Huajun Zhang, Yujun Feng, Yanyan Wang, Xueying Wang, Suyan Gao, Lixia Dong, Xin Zhao, Huiqing Li, Liwei Li and 1 more

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rui LiDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.ORCID 0000-0002-0997-8895
Huajun ZhangDepartment of Clinical Medicine, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Yujun FengDepartment of Clinical Medicine, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Yanyan WangDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Xueying WangDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Suyan GaoDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Lixia DongDepartment of Clinical Medicine, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Xin ZhaoDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Huiqing LiDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Liwei LiDepartment of Gynecology, Qinhuangdao Maternity and Child Health Hospital, Qinhuangdao, Hebei, China.
Xiyu GuoHealth Clinic, Chinese People's Liberation Army Veteran Cadres Service Administration in Beijing, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Menopausal hormone therapy (MHT) has been receiving increasing attention in developed countries. The purpose of this study was to investigate understanding of menopause and acceptance of MHT in Qinhuangdao, China. MATERIAL AND METHODS We analyzed data from 186 perimenopausal patients on topics including menopausal symptoms and acceptance of and adherence to MHT treatment. We also surveyed 100 medical staff on menopausal-related knowledge. RESULTS Group A consisted of 41 patients treated with MHT for more than 1 cycle, group B consisted of 49 patients who had received MHT but had stopped it for more than 3 months, and group C consisted of 96 patients who never received MHT. There was a significant difference among them in modified Kupermann scores before treatment (P<0.05), but the difference disappeared after MHT (P>0.05). In group C, 32 patients (33%) were unaware of MHT, 60 (62.5%) were worried about the risk of breast/endometrial cancer, 24 (25%) were worried about high costs, and 67 (70%) had no obvious symptoms and did not want MHT. Similarly, in group B, most people stopped MHT for fear of breast or endometrial cancer. A survey targeting 100 medical staff in our hospital found 14 people (14%) knew about and were willing to accept MHT, 44 people (44%) knew about MHT but were afraid to use it, and 42 people (42%) did not know about MHT at all. CONCLUSIONS MHT has not yet been accepted by the majority of people, even medical staff, in Qinhuangdao, China, and much further progress is needed.

Indexed as

Health Knowledge, Attitudes, PracticeMenopauseAdultBreast NeoplasmsChinaEstrogen Replacement TherapyFemaleHormone Replacement TherapyHumansMiddle AgedSurveys and Questionnaires

Identifiers

PMID39238178
PMCPMC11382616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.